🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to estimate the risk of bleeding with rivaroxa...
Status
Completed
Location
Multiple Locations
Start Date
2015-04-20
Trial ID
NCT02293395
Treatments Being Tested
A prospective, randomised, open label study of 3 clinically licensed treatm...
Status
Unknown
Location
East and North Hertfordshire NHS Trust
Start Date
2019-01-08
Trial ID
NCT03775746
Treatments Being Tested
The goal of this clinical trial is to compare the safety and effectiveness ...
Status
Unknown
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2023-09-29
Trial ID
NCT06058130
Treatments Being Tested
A total of 50 participants diagnosed with ACS (group A ticagrelor 180mg/d, ...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2017-04-12
Trial ID
NCT03481257
A registry of patients from the Asia-Pacific region with PFO and ischemic s...
Status
Not Yet Recruiting
Location
National University Hospital
Start Date
2025-07
Trial ID
NCT06983795
Treatments Being Tested
Recent studies indicate that anti-factor-Xa inhibition with low-dose rivaro...
Status
Completed
Location
Cardiovascular Research Center,
Start Date
2019-01-14
Trial ID
NCT03718429
Treatments Being Tested
This prospective cohort study will provide information about: characteristi...
Status
Completed
Location
Multiple Locations
Start Date
2011-12-22
Trial ID
NCT01947959
Treatments Being Tested
The primary goal of the trial is to determine if the experimental arms (riv...
Status
Active Not Recruiting
Location
University of Alabama Hospital
Start Date
2022-08-02
Trial ID
NCT05047172
Treatments Being Tested
To screen ischemic stroke patients likely to benefit from anticoagulation a...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-15
Trial ID
NCT07746882
Treatments Being Tested
APERITIF is a prospective randomized open-label, blinded end-point (PROBE) ...
Status
Completed
Location
HEGP
Start Date
2021-10-10
Trial ID
NCT05077683
Treatments Being Tested